| Financial Year |
March 31 2023 |
| Monetary Funds |
176,643,633.76 |
| Held-for-trading Financial Assets |
654,700,075.67 |
| Notes Receivable |
1,343,233.61 |
| Accounts Receivable |
302,382,334.07 |
| Advances to Suppliers |
61,973,127.16 |
| Other Receivables |
26,570,864.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
237,877,658.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,653,718.35 |
| Other Current Assets |
123,045,981.49 |
| Total Current Assets |
1,592,380,219.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
45,154,151.70 |
| Long-term Equity Investment |
351,636,022.74 |
| Investment Properties |
19,306,481.38 |
| Fixed Assetes |
128,085,741.95 |
| Under-construction Projects |
487,208,632.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
292,921,011.83 |
| R&D expenses |
7,150,714.60 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,010,577.11 |
| Deferred Income Tax Assets |
68,348,499.20 |
| Other Non-Current Assets |
4,097,297.64 |
| Sub-Total of Non-Current Assets |
1,404,919,130.88 |
| Total Assets |
2,997,299,350.81 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
63,558,676.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,711,992.01 |
| Taxes Payable |
35,939,833.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,045,924.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,070,147.77 |
| Other Current Liabilities |
5,111,058.78 |
| Sub-Total of Current Liabilities |
208,774,364.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,738,369.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
408,317.33 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,255,742.80 |
| Total Liabilities |
263,030,107.04 |
| Paid-In Capital(Or Share Stock) |
1,446,495,310.00 |
| Capital Surplus |
3,383,070,198.35 |
| Surplus Reserve |
62,599,176.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,152,353,686.03 |
| Minority Stockholder's Interest |
244,946.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,734,024,297.04 |
| Owner's Equity（Stockholder's Equity） |
2,734,269,243.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,997,299,350.81 |
